2025. Health, risks and disease in therapeutic functionalities of Glucagon-like peptide-1 receptoragonists (GLP-1RAs) concerning human susceptibility. Greenfort International Journal of Applied Medical Science. 3, 5 (Oct. 2025), 240–254. DOI:https://doi.org/10.62046/gijams.2025.v03i05.002.